0001209191-21-031435.txt : 20210510 0001209191-21-031435.hdr.sgml : 20210510 20210510194847 ACCESSION NUMBER: 0001209191-21-031435 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210507 FILED AS OF DATE: 20210510 DATE AS OF CHANGE: 20210510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Butt Tausif CENTRAL INDEX KEY: 0001845266 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 21909150 MAIL ADDRESS: STREET 1: C/O CHEMOCENTRYX, INC. STREET 2: 850 MAUDE AVE. CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 835 INDUSTRIAL ROAD STREET 2: SUITE 600 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 835 INDUSTRIAL ROAD STREET 2: SUITE 600 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-07 0 0001340652 ChemoCentryx, Inc. CCXI 0001845266 Butt Tausif C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 0 1 0 0 EVP, Chief Operating Officer Common Stock 2021-05-07 4 P 0 10870 11.0617 A 10870 D Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $11.02 to $11.12 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. /s/ Susan M. Kanaya, as Attorney-in-Fact 2021-05-10